Verve Therapeutics announced the appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its board of directors. Dr. Tatsis currently serves as executive vice president, chief regulatory and quality officer, of Vertex Pharmaceuticals. Ms. Morrison currently serves as chief executive officer and director of Q32 Bio Inc. Nia Tatsis, Ph.D., joined Vertex Pharmaceuticals in 2017 and serves as the company?s executive vice president, chief regulatory and quality officer.

Prior to joining Vertex, Dr. Tatsis held positions of increasing responsibility at pharmaceutical companies including Sanofi, Pfizer, and Wyeth. Most recently, she served as vice president, head of global regulatory affairs, of the Sanofi Genzyme Business Unit. Dr. Tatsis currently serves as a member of the leadership council of the International Institute of New England.

Previously, she served as a staff scientist and research fellow in immunology and vaccine development at the Wistar Institute. Dr. Tatsis received her Ph.D. in cell and molecular biology from the University of Vermont and completed a postdoctoral research fellowship in immunology at Thomas Jefferson University. She holds a B.S. in biology from Temple University.

Jodie Morrison, chief executive officer and director of Q32 Bio Inc., brings two decades of biopharmaceutical leadership experience across private and public biotechnology and pharmaceutical companies from start-up to commercial stage. Ms. Morrison was previously chief executive officer of Cadent Therapeutics until its sale to Novartis in 2021. Ms. Morrison also served as interim chief executive officer of Keryx Biopharmaceuticals, Inc. (executed its merger of equals with Akebia Therapeutics, Inc. in 2018), acting chief operating officer of Syntimmune, Inc. (acquired by Alexion Pharmaceuticals, Inc.), and president and chief executive officer of Tokai Pharmaceuticals, Inc., where she oversaw the company?s successful initial public offering (IPO) in 2014.

Ms. Morrison currently serves as an advisor to Atlas Venture, where she previously served as a venture partner, and as a member of the board at Rectify Pharma and of the board of managers at Life Science Cares. Ms. Morrison holds a B.A. in neuroscience from Mount Holyoke College.